| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2002 | WO2002017735A3 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 09/12/2002 | WO2002014252A3 Compositions containing hypoglycemically active stilbenoids |
| 09/12/2002 | WO2002013796A3 Use of proton pump inhibitors for treating diseases of the locomotor system |
| 09/12/2002 | WO2002003990A3 Use of substituted insole compounds for treating excessive intraocular pressure |
| 09/12/2002 | WO2002002096A3 Oral compositions comprising host-response modulating agent |
| 09/12/2002 | WO2001097801A3 Dry powder formulation comprising racecadotril |
| 09/12/2002 | WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists |
| 09/12/2002 | WO2001093914A3 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 09/12/2002 | WO2001092543A3 Improved methods of transfection |
| 09/12/2002 | WO2001091770A3 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001091769A3 Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001091768A3 Compositions for treating brain disorders and enhancing brain function, containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001091767A3 Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001091741A3 Compositions containing hexitol and an antiproliferative agent |
| 09/12/2002 | WO2001089530A3 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001085218A3 Acylated cyclodextrin guest inclusion complexes |
| 09/12/2002 | WO2001085175A3 Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with ns398 or pdtc |
| 09/12/2002 | WO2001077360A3 Methods for ansamitocin production |
| 09/12/2002 | WO2001074339A3 A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 09/12/2002 | WO2001068078A3 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/12/2002 | WO2001047562A3 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 09/12/2002 | WO2001047509A3 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
| 09/12/2002 | WO2001047497A3 Controlled release pharmaceutical composition containing tramadol hydrochloride |
| 09/12/2002 | WO2001045681A3 Naphthoquinone derivatives as cd45 inhibitors |
| 09/12/2002 | WO2001045641A3 Inhibitors of thrombin induced platelet aggregation |
| 09/12/2002 | WO2001041768A9 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/12/2002 | WO2001041753A3 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/12/2002 | WO2001041752A3 Use of isoform specific inhibitors of cgmp-dependent protein kinase for treatment of pain |
| 09/12/2002 | WO2001040232A9 Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001036510A3 Use of poly(diallylamine) polymers |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001034174A3 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 09/12/2002 | WO2001034126A9 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001028539A3 Agent for treating cephalic pain |
| 09/12/2002 | WO2001017526A9 Treatment of skin disorders |
| 09/12/2002 | WO2001015700A9 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 09/12/2002 | WO2001015694A9 Extended duration light activated cancer therapy |
| 09/12/2002 | WO2001015680A9 Composition for treatment of infections of humans and animals |
| 09/12/2002 | WO2001013933A9 Agents for the enhanced oxygen delivery in mammals |
| 09/12/2002 | WO2001012247A9 Tissue augmentation material and method |
| 09/12/2002 | WO2001010901A9 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020128591 Transdermal electrotransport device and method for manufacturing same |
| 09/12/2002 | US20020128553 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/12/2002 | US20020128527 Use in medicine, pharmacy, biology and technology, friction-reducing additives in engines |
| 09/12/2002 | US20020128512 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering |
| 09/12/2002 | US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 09/12/2002 | US20020128493 Synthetic methods for polyphenols |
| 09/12/2002 | US20020128483 Sulfonamide-containing indole compounds |
| 09/12/2002 | US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/12/2002 | US20020128480 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 09/12/2002 | US20020128477 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 09/12/2002 | US20020128475 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders |
| 09/12/2002 | US20020128471 Useful for treating cellular hyperproliferation |
| 09/12/2002 | US20020128447 Pharmaceutical composition containing IL-10 |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128442 Human proteins STAM2a and STAM2b, and cDNAs encoding these molecules |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128434 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/12/2002 | US20020128326 Topical immunomodulating compositions for treatment of aids, hepatitis b&c, other infectious diseases, and cancer |
| 09/12/2002 | US20020128325 Process for producing dry powders of one or more carotenoids |
| 09/12/2002 | US20020128324 Process for decreasing adiposity using Vitamin A as a dietary supplement |
| 09/12/2002 | US20020128323 Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same |
| 09/12/2002 | US20020128322 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 09/12/2002 | US20020128321 IL-8 receptor antagonists |
| 09/12/2002 | US20020128320 For increasing the high-density lipoprotein level in plasma in postmenopausal women |
| 09/12/2002 | US20020128319 Abeta 42 lowering agents |
| 09/12/2002 | US20020128317 Administering diacerein or rhein to treat inflammatory and autoimmune conditions characterized by an increased IL-1 and or TNF alpha level |
| 09/12/2002 | US20020128316 Neuroprotective composition and uses thereof |
| 09/12/2002 | US20020128314 Suppository comprising: a prostaglandin vasodilator; 15-hydroxyprostaglandindehydrogenase inhibitor: and a base material that is solid at room temperature and releases the components when inserted in the urethra, |
| 09/12/2002 | US20020128313 Administering to the herd native or extended semen with a simultaneous or sequential administration of prostaglandin |
| 09/12/2002 | US20020128310 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammtory formulation |
| 09/12/2002 | US20020128309 Particularly atheriosclerosis, cancer, infection or other inflammatory diseases |
| 09/12/2002 | US20020128307 Tetramic acid-type compounds isolated from a CCR-5 active complex produced by fermentation under controlled conditions of a biologically pure culture of the microorganism, Chaetomium globosum Kunze |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128305 Administering an indole derivative such as 1-(4-(2-Azepan-1yl-ethoxy)-benzyl)-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5 -o l, or 2-(4-Hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl ethoxy)-benzyl)-1H-indol-5-ol |
| 09/12/2002 | US20020128304 Administering as anticarcinogenic agent |
| 09/12/2002 | US20020128303 Injection with a photodynamic compound having tumor selective uptake which is activated at a particular light frequency; injection with a xanthenone-4-acetic acid or salt; exposing the tumor to light at the activation frequency |
| 09/12/2002 | US20020128302 Use of a CB1 receptor antagonist for the preparation of drugs useful in the treatment of appetency disorders, such as obesity associated with non-insulin- dependent diabetes and drug dependence |
| 09/12/2002 | US20020128300 Medicament |
| 09/12/2002 | US20020128299 Treating a disorder of the vasculature |
| 09/12/2002 | US20020128298 Methods for increasing leptin levels using nicotinic acid compounds |
| 09/12/2002 | US20020128297 Amlodipine hemimaleate |
| 09/12/2002 | US20020128295 Hyperlipidemia, renal disease, proliferation or smooth muscle cells in the aorta, coronary artery occlusion, atherosclerosis, hypertension, advanced glycation end-product formation and advanced lipoxidation end-product formation. |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128293 Water insoluble polymer, such as crosslinked polyvinylpyrrolidone or vinyl acetate-vinylpyrrolidone copolymer, as a carrier which acts as a stabilizing excipient |
| 09/12/2002 | US20020128292 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/12/2002 | US20020128291 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome |
| 09/12/2002 | US20020128290 Derivatives of benzofuran or benzodioxole |
| 09/12/2002 | US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 09/12/2002 | US20020128288 Useful in the treatment of chronic and acute pain. |
| 09/12/2002 | US20020128287 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/12/2002 | US20020128286 Isoindolyl and isoquinolinyl aroyl pyrrole compounds |
| 09/12/2002 | US20020128285 Topical delivery of a local anesthetic |
| 09/12/2002 | US20020128284 Tropane-derivatives, their preparation and use |